References
- Rechthand E, Rapaport SI. Regulation of the micro-environment of peripheral nerve: role of the blood-nerve barrier. Prog Neurobiol 1987; 28: 303–43.
- Schinkel AH, Smit JJM, van Tellingen 0, et al. Disruption of the mouse mdrla p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502.
- Saito T, Zhang Z-J, Shibamori Y, et al. P-glycoprotein expression in capillary endothelial cells of the 7th and 8th nerves of guinea pig in relation to blood-nerve barrier sites. Neurosci Lett 1997; 232: 41–4.
- Saito T, Zhang Z-J, Ohtsubo T, et al. Homozygous disruption of the mdrla p-glycoprotein gene affects blood-nerve barrier in mice administered with neuro-toxic drugs. Acta Otolaryngol 2001; 121: 735–42.
- Colombo T, Zucchetti M, D'Incalci M. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. J Pharmacol Exp Ther 1994; 269: 22–7.
- Lyubimov E, Lan L-B, Pashinsky I, Stein WD. Effect of modulators of the multidrug resistance pump on the distribution of vinblastine in tissues of the mouse. Anticancer Drugs 1996; 7: 60–9.
- Arboix M, Paz OG, Colombo T, D'Incalci M. Multi-drug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis. J Pharmacol Exp Ther 1997; 281: 1226–30.
- Bellamy WT, Peng YM, Odeleye A, et al. Cardiotoxicity in the SCID mouse following administration of doxor-ubicin and cyclosporin A. Anticancer Drugs 1995; 6: 736–43.
- Saito T, Zhang Z-J, Tokuriki M, et al. Expression of p-glycoprotein is associated with that of multidrug resis-tance protein 1 (MRP1) in the vestibular labyrinth and endolymphatic sac of the guinea pig. Neurosci Lett 2001; 303: 189–92.
- Saito T, Zhang Z-J, Tokuriki M, et al. Expression of multidrug resistance protein 1 (MRP1) in the rat cochlea with special reference to the blood-inner ear barrier. Brain Res 2001; 895: 253–7.
- Zhang Z-J, Saito T, Kimura Y, Sugimoto C, Ohtsubo T, Saito H. Disruption of mdrla p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice. Brain Res 2000; 852: 116–26.
- Saito T, Zhang Z-J, Tokuriki M, et al. Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin. Brain Res 2001; 901: 265–70.
- Saito T, Zhang Z-J, Tokuriki M, et al. Doxorubucin ototoxicity is induced in mice by combination treatment with cyclosporin A. Acta Otolaryngol 2001; 121: 787–93.
- Barbui T, Rambaldi A, Parenzan L, Zucchelli M, Perico N, Remuzzi G. Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapy. Lancet 1992; 339: 1421.
- Bertrand Y, Capdeville R, Balduck N, Philippe N. Cyclosporin A used to reverse drug resistance increases vincristine neurotoxicity. Am J Hematol 1992; 40: 158–9.